Company Directory > MedTech > Telemed UAB
Telemed is a pioneer in the development and manufacturing of PC-based ultrasound imaging systems and OEM components. Founded in 1992 in Vilnius, Lithuania, the company focuses on creating portable, high-performance, and cost-effective ultrasound solutions for medical, veterinary, and research applications. Their open-architecture platform allows their technology to be integrated into various computing environments, including PCs, tablets, and mobile devices. Telemed operates as both a direct manufacturer of branded ultrasound scanners (such as the ArtUs and MicrUs series) and a strategic OEM partner for other medical device companies. With a strong emphasis on innovation, they have maintained a global presence for over three decades, providing advanced beamforming technology and imaging software to clinicians and researchers in more than 80 countries.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Diagnostic Imaging / Ultrasound
SIZE & FINANCIALS
Employees:1-50
Founded:1992
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Modalities:Ultrasound
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various OEM partners globally for ultrasound component integration
COMPETITION
Position:Niche Player
Competitors:GE HealthCare, Philips Healthcare, Mindray, Fujifilm Sonosite, Butterfly Network
LEADERSHIP
Key Executives:
Yury Sokolov - Engineering Manager
LINKS
Website:telemed.lt
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Telemed UAB and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Telemed UAB. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.